Australia markets closed

AdaptHealth Corp. (AHCO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.10-0.14 (-1.93%)
At close: 04:00PM EST
7.26 +0.16 (+2.25%)
After hours: 08:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 969.05M
Enterprise value 3.22B
Trailing P/E N/A
Forward P/E 10.27
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.31
Price/book (mrq)0.56
Enterprise value/revenue 1.04
Enterprise value/EBITDA 45.20

Trading information

Stock price history

Beta (5Y monthly) 1.00
52-week change 3-68.15%
S&P500 52-week change 324.01%
52-week high 322.94
52-week low 36.37
50-day moving average 37.30
200-day moving average 39.62

Share statistics

Avg vol (3-month) 31.15M
Avg vol (10-day) 31.53M
Shares outstanding 5136.39M
Implied shares outstanding 6136.39M
Float 877.28M
% held by insiders 116.75%
% held by institutions 184.71%
Shares short (31 Jan 2024) 410.33M
Short ratio (31 Jan 2024) 412.43
Short % of float (31 Jan 2024) 49.63%
Short % of shares outstanding (31 Jan 2024) 47.58%
Shares short (prior month 29 Dec 2023) 410.02M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023


Profit margin -13.67%
Operating margin (ttm)7.23%

Management effectiveness

Return on assets (ttm)2.39%
Return on equity (ttm)-21.68%

Income statement

Revenue (ttm)3.12B
Revenue per share (ttm)23.22
Quarterly revenue growth (yoy)6.30%
Gross profit (ttm)N/A
EBITDA 583.55M
Net income avi to common (ttm)-426.77M
Diluted EPS (ttm)-3.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)62.48M
Total cash per share (mrq)0.46
Total debt (mrq)2.3B
Total debt/equity (mrq)132.36%
Current ratio (mrq)1.30
Book value per share (mrq)12.83

Cash flow statement

Operating cash flow (ttm)422.32M
Levered free cash flow (ttm)31.06M